Library
BCM-95® (CURCUGREEN®), 20 Mar 2021
Published on : Human Molecular Genetics, Volume 24, Issue 15, 1 August 2015, Pages 4198–4211, https://doi.org/10.1093/hmg/ddv153 Published: 29 April 2015
Massimo Tatti, Marialetizia Motta, Susanna Scarpa, Sabrina Di Bartolomeo, Valentina Cianfanelli, Marco Tartaglia, Rosa Salvioli
https://doi.org/10.1093/hmg/ddv153
Saposin (Sap) C deficiency is a rare variant form of Gaucher disease caused by impaired Sap C expression or accelerated degradation, and associated with accumulation of glucosylceramide and other lipids in the endo/lysosomal compartment. No effective therapies are currently available for the treatment of Sap C deficiency. We previously reported that a reduced amount and enzymatic activity of cathepsin (Cath) B and Cath D, and defective autophagy occur in Sap C-deficient fibroblasts. Here, we explored the use of two compounds, BCM-95, a curcumin derivative, and (2-hydroxypropyl)-β-cyclodextrin (HP-β-CD), to improve lysosomal function of Sap C-deficient fibroblasts. Immunofluorescence and biochemical studies documented that each compound promotes an increase of the expression levels and activities of Cath B and Cath D, and efficient clearance of cholesterol (Chol) and ceramide (Cer) in lysosomes. We provide evidence that BCM-95 and HP-β-CD enhance lysosomal function promoting autophagic clearance capacity and lysosome reformation. Our findings suggest a novel pharmacological approach to Sap C deficiency directed to treat major secondary pathological aspects in this disorder.
© The Author 2015. Published by Oxford University Press. All rights reserved.
Let’s collaborate to refine your ideas or built from scratch
Arjuna Natural is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for more than two decades. Established in 1989, the company has grown...Read More